NCAM1 and COVID-19: When comparing classical monocytes from convalescent COVID-19 patients (n=18) and uninfected controls (n=31), we found no significant differences in the percentages of cells expressing bright (T-cell intensity) CD4, CD56, CD69, CD83, or CD86 in the absence of LPS stimulation (Figure 4).